… MDA-LDL was independently associated with time to incident major adverse cardiovascular
events … understanding of differences in ethnic-specific major adverse cardiovascular events. …

… LDL (oxLDL), malondialdehyde-LDL (MDA-LDL) and advanced glycation end products-…
levels of MDA-LDL in IC predict future acute CV events in the VADT cohort. ► MDA-LDL in …

… In this study, 332 patients whose MDA-LDL was measured before PCI with DES were …
prevention of coronary artery disease [7]. However, recurrent cardiovascular events may occur in …

… level is a direct cause or a result of ISR and cardiac events, this study showed that high
levels of circulating MDA-LDL can serve as a significant predictor of ISR and cardiac events in …

… However, MDA-LDL IgM levels were significantly lower in patients in the CVE group (9524
± … the event-free (10 975 ± 5398 RLU) group (P = .04). In conclusion, levels of MDA-LDL IgM …

… as the incidence of major adverse limb events (MALE), major adverse cardiovascular events
(MACE) and major adverse cardiovascular and limb events (MACLE). MALE was defined …

… Patients 20 years of age or older and at high risk for cardiovascular events whose serum
LDL-C level had not reached the management target value determined according to the Japan …

… malondialdehyde LDL prepared in vitro (MDA-LDL) are at a high risk of acute vascular events,
… are more prone to rupture and responsible for the majority of acute cardiovascular events. …

… (AA) to malondialdehyde (MDA)-LDL and apoB-immune … their association to coronary artery
disease (CAD) events determined. … to malondialdehyde-modified LDL (MDA-LDL) as initially …

… Individually, OxPL/apoB and IgG Cu-OxLDL autoantibodies predicted a higher event rate,
whereas IgM MDA-LDL (or IgM Cu-OxLDL) autoantibodies predicted a lower event rate. …